However, it is now known that only about 5% of nephroblastoma incidence is caused by mutations in WT1; and most Wilms’ tumors exhibit high levels of WT1, which is also the case for most solid cancers as well as leukemia. This evidence concerns the gene WT1 and Nephroblastoma.